2004•Journal of the American College of SurgeonsRequires access

Post-transcriptional silencing of BCL-XL in mesothelioma using synthesized oligonucleotides and an H1 promoter driven vector encoding siRNA

Jonathan C. Daniel, Xiaobo X. Cao, Philip A. Rascoe, S. D. Miller, Roy W. Smythe

Open publisher page 0 citations

Abstract

Daniel, Jonathan C. MD; Cao, Xiaobo MD; Rascoe, Philip A. MD; Miller, Steven D. MD; Smythe, Roy W. MD, FACS Author Information

About this research paper

What this paper is about

Daniel, Jonathan C. MD; Cao, Xiaobo MD; Rascoe, Philip A. MD; Miller, Steven D. MD; Smythe, Roy W. MD, FACS Author Information

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Daniel, Jonathan C. MD; Cao, Xiaobo MD; Rascoe, Philip A. MD; Miller, Steven D. MD; Smythe, Roy W. MD, FACS Author Information

Key concepts: Medicine, Gene silencing, Oligonucleotide, Molecular biology, Vector (molecular biology), Genetics, Gene, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Post-transcriptional silencing of BCL-XL in mesothelioma using synthesized oligonucleotides and an H1 promoter driven vector encoding siRNA — Research Paper | ScholarLens